Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study
- PMID: 16461191
- DOI: 10.1016/j.amjhyper.2005.07.011
Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study
Abstract
Background: The Hypertension Study in General Practice in Hellas (Hypertenshell) is a cross-sectional study (much like the National Health and Nutrition Examination Study) for assessing the prevalence, level of awareness, treatment, and control of hypertension in Greece.
Methods: The study was conducted with the collaboration of physicians in 98 Health Centers across Greece. Participants were interviewed about lifestyle, and blood pressure (BP) measurements were taken on two clinical visits for verification of diagnosis and control of hypertension. Hypertension was defined as systolic BP > or =140 mm Hg or diastolic BP > or =90 mm Hg, or current treatment with antihypertensive drugs; the same threshold was used for assessing control of hypertension.
Results: A total of 11,950 individuals participated and data for 11,540 were analyzed, comprising 0.1% of the Greek population. The prevalence of hypertension was 31.1% (men 33.6%, women 28.4%); among elderly individuals (>65 years) the prevalence was higher (65.4%). Of the hypertensive individuals, 39.8% did not know that had hypertension, yielding an awareness of 60.2%; in addition, 12.4% were aware but not treated (men 13.1%, women 11.8%). In all, 51.2% (1838) of hypertensive subjects were treated; 67.2% (1235) were treated but not controlled (men 66.7%, women 67.7%); and 32.8% (603) were treated and controlled (men 33.3%, women 32.3%).
Conclusions: The results of the Hypertenshell Study indicate that hypertension is a common risk factor for cardiovascular disease in the Greek population. Awareness, treatment, and control of hypertension are comparable to the best rates of control of hypertension given for the problem, but there is a considerable potential for further improvement in the control of this disease.
Similar articles
-
Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece.Rural Remote Health. 2010 Apr-Jun;10(2):1225. Epub 2010 Apr 6. Rural Remote Health. 2010. PMID: 20373843
-
[Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):407-11. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15231166 Chinese.
-
Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study.J Hum Hypertens. 2004 Sep;18(9):623-9. doi: 10.1038/sj.jhh.1001724. J Hum Hypertens. 2004. PMID: 15029221
-
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia.J Hum Hypertens. 2004 Aug;18(8):545-51. doi: 10.1038/sj.jhh.1001701. J Hum Hypertens. 2004. PMID: 15269704 Review.
-
[Prevalence of hypertension and its treatment in a population of 26,374 workers].Arch Mal Coeur Vaiss. 1992 Mar;85(3):351-7. Arch Mal Coeur Vaiss. 1992. PMID: 1575614 Review. French.
Cited by
-
1999-2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland.PLoS One. 2012;7(6):e39877. doi: 10.1371/journal.pone.0039877. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761919 Free PMC article.
-
Aims, design and preliminary findings of the Hellenic National Nutrition and Health Survey (HNNHS).BMC Med Res Methodol. 2019 Feb 20;19(1):37. doi: 10.1186/s12874-018-0655-y. BMC Med Res Methodol. 2019. PMID: 30786873 Free PMC article.
-
Prevalence and Associated Factors of Prehypertension and Hypertension in Iranian Population: The Lifestyle Promotion Project (LPP).PLoS One. 2016 Oct 26;11(10):e0165264. doi: 10.1371/journal.pone.0165264. eCollection 2016. PLoS One. 2016. PMID: 27783691 Free PMC article.
-
Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018.Curr Hypertens Rev. 2019;15(2):113-122. doi: 10.2174/1573402115666190118142818. Curr Hypertens Rev. 2019. PMID: 30657043 Free PMC article.
-
First renin inhibitor, aliskiren, for the treatment of hypertension.Pharm World Sci. 2008 Dec;30(6):741-9. doi: 10.1007/s11096-008-9252-1. Epub 2008 Sep 18. Pharm World Sci. 2008. PMID: 18802783 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical